Harnessing AI-Driven Drug Discovery to Accelerate Next-Generation DDR Therapeutics
• See Rakovina Therapeutic’s journey of pivoting a DDR-focused biotech to a fully AI-driven discovery model
• Illustrating case studies of AI-designed DDR programs advancing through preclinical lead selection
• Evaluating predictive accuracy, translational potential, and long-term impact of AI on drug development